Brookstone Capital Management Abb Vie Inc. Transaction History

Brookstone Capital Management

$6.01 Billion
Q3 2024

A detailed history of Brookstone Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Brookstone Capital Management holds 87,894 shares of ABBV stock, worth $17.6 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

87,894

Previous 88,188 0.33%

Holding current value

$17.6 Million

Previous $15.1 Million 14.75%

% of portfolio

0.29%

Previous 0.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$163.84 - $199.33 $48,168 - $58,603	-294 Reduced 0.33%	87,894 $17.4 Million
Q2 2024 Jul 18, 2024	BUY	$154.79 - $180.76 $801,038 - $935,433	5,175 Added 6.23%	88,188 $15.1 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $480,418 - $547,392	3,006 Added 3.76%	83,013 $15.1 Million
Q4 2023 Jan 11, 2024	BUY	$137.6 - $154.97 $486,553 - $547,973	3,536 Added 4.62%	80,007 $12.4 Million
Q3 2023 Oct 20, 2023	SELL	$133.59 - $154.65 $2.69 Million - $3.12 Million	-20,164 Reduced 20.87%	76,471 $11.4 Million
Q2 2023 Jul 11, 2023	BUY	$132.51 - $164.9 $1.08 Million - $1.34 Million	8,119 Added 9.17%	96,635 $13 Million
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $998,965 - $1.15 Million	6,908 Added 8.46%	88,516 $14.1 Million
Q4 2022 Jan 09, 2023	SELL	$138.31 - $165.87 $1.51 Million - $1.81 Million	-10,894 Reduced 11.78%	81,608 $0
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $2.07 Million - $2.38 Million	-15,456 Reduced 14.32%	92,502 $12.9 Million
Q2 2022 Jul 11, 2022	BUY	$137.62 - $174.96 $1.7 Million - $2.16 Million	12,368 Added 12.94%	107,958 $16.5 Million
Q1 2022 Apr 12, 2022	SELL	$131.98 - $163.75 $4.11 Million - $5.1 Million	-31,151 Reduced 24.58%	95,590 $16.2 Million
Q4 2021 Jan 11, 2022	SELL	$107.43 - $135.93 $157,492 - $199,273	-1,466 Reduced 1.14%	126,741 $17.1 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $2.41 Million - $2.73 Million	22,634 Added 21.44%	128,207 $13.9 Million
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $4.22 Million - $4.7 Million	40,090 Added 61.22%	105,573 $12.4 Million
Q1 2021 Apr 16, 2021	SELL	$102.3 - $112.62 $445,414 - $490,347	-4,354 Reduced 6.23%	65,483 $7.09 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $368,966 - $498,143	4,584 Added 7.02%	69,837 $7.48 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $1.64 Million - $1.93 Million	19,130 Added 41.48%	65,253 $5.72 Million
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $936,421 - $1.25 Million	-12,763 Reduced 21.67%	46,123 $4.53 Million
Q1 2020 Apr 14, 2020	SELL	$64.5 - $97.79 $695,181 - $1.05 Million	-10,778 Reduced 15.47%	58,886 $4.49 Million
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $709,759 - $888,060	9,840 Added 16.45%	69,664 $6.17 Million
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $930,088 - $1.12 Million	14,768 Added 32.78%	59,824 $4.53 Million
Q2 2019 Jul 25, 2019	BUY	$65.7 - $83.98 $422,451 - $539,991	6,430 Added 16.65%	45,056 $3.28 Million
Q1 2019 Apr 18, 2019	BUY	$77.14 - $90.79 $1.14 Million - $1.34 Million	14,811 Added 62.19%	38,626 $3.11 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $165,275 - $203,829	2,123 Added 9.79%	23,815 $2.2 Million
Q3 2018 Nov 05, 2018	BUY	$88.91 - $98.84 $323,365 - $359,481	3,637 Added 20.14%	21,692 $2.05 Million
Q2 2018 Aug 06, 2018	BUY	$89.78 - $106.23 $522,968 - $618,789	5,825 Added 47.63%	18,055 $1.67 Million
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $146,663 - $196,396	1,594 Added 14.99%	12,230 $1.16 Million
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $5.34 Million - $5.86 Million	-59,680 Reduced 84.87%	10,636 $1.03 Million
Q3 2017 Oct 31, 2017	SELL	$69.85 - $89.22 $1.4 Million - $1.79 Million	-20,010 Reduced 22.15%	70,316 $6.25 Million
Q2 2017 Aug 08, 2017	BUY	N/A	90,326	90,326 $6.55 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Account

Brookstone Capital Management Abb Vie Inc. Transaction History